EEG changes in patients with Alzheimer’s disease

Close metadata

Recommended articles:

Prevalence of cognitive impairment in older adults in the Russian Federation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):5-11

Cognitive impairment in cerebrovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):12-16

Comparative characteristics of neuropsychological and neurometabolic changes in patients with Alzheimer’s disease and vascular cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):17-24

Impairment of attention and executive functions in chronic cerebrovascular disease and Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):25-32

Assessment of the significance of dilated perivascular spaces and nocture arterial hypertension in the development of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):33-40

Traumatic brain injury as risk factor of Alzheimer’s disease and possibilities of pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(1):45-54

Use of modern classification systems for complex diagnostics of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(1):121-127

Validation of screening method based on EEG analysis for the risk assessment of psychiatric and behavioral disorders: a pilot study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):88-96

Glymphatic dysfunction and sleep disorders: indirect effects on Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):7-12

Ginkgolide B: mechanisms of neurobiological effects, prospects for use in the therapy of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):22-27

The prevalence of cognitive impairment is steadily increasing compared to previous years. According to the World Health Organization, the number of people living with dementia will increase reaching 82 million in 2030 and 152 million in 2050. The most common cause is Alzheimer’s disease (AD). The pathophysiological process in AD begins several years before the onset of clinical symptoms; so identifying it at an early stage would likely improve the clinical prognosis. The article presents EEG changes in patients with AD, and discusses the possibility of using EEG as a screening method for examining patients with cognitive impairment.

Keywords:

dementia

Alzheimer’s disease

EEG

spectral analysis

coherence

Authors:

Burd S.G.

Federal Center of Brain Research and Neurotechnologies;
Pirogov Russian National Research Medical University;
Scientific and Practical Center for Child Psychoneurology

ORCID: 0000-0003-0804-7076

Lebedeva A.V.

Federal Center of Brain Research and Neurotechnologies;
Pirogov Russian National Research Medical University

SPIN RSCI: 3515-2408
Scopus AuthorID: 57193881028
ORCID: 0000-0001-8712-4775

Rubleva Yu.V.

Federal Center of Brain Research and Neurotechnologies

ORCID: 0000-0002-3746-1797

Pantina N.V.

Federal Center of Brain Research and Neurotechnologies

ORCID: 0000-0003-2730-7662

Efimenko A.P.

Federal Center of Brain Research and Neurotechnologies

ORCID: 0009-0007-9066-7907

Kovaleva I.I.

Federal Center of Brain Research and Neurotechnologies

ORCID: 0000-0002-8496-7475

Received:

07.02.2024

Accepted:

13.02.2024

List of references:

Hakim AM. A Proposed Hypothesis on Dementia: Inflammation, Small Vessel Disease, and Hypoperfusion Is the Sequence That Links All Harmful Lifestyles to Cognitive Impairment. Front Aging Neurosci. 2021;13:679837. https://doi.org/10.3389/fnagi.2021.679837
Patterson C. World Alzheimer report 2018. The state of the art of dementia research: New frontiers. London: 2018. Alzheimer’s Disease International (ADI), London. Data Accessed 25.01.24 https://www.alzint.org/u/WorldAlzheimerReport2018.pdf
Niu H, Álvarez-Álvarez I, Guillén-Grima F, et al. Prevalence and incidence of Alzheimer’s disease in Europe: A meta-analysis. Prevalencia e incidencia de la enfermedad de Alzheimer en Europa: metaanálisis. Neurologia. 2017;32(8):523-532. https://doi.org/10.1016/j.nrl.2016.02.016
Bogolepova AN, Vasenina EE, Gomzyakova NA, et al. Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients. S.S. Korsakov Journal of Neurology and Psichiatry. 2021;121(10-3):6-137. (In Russ.). https://doi.org/10.17116/jnevro20211211036
Vasenina EE, Levin OS, Sonin AG. Modern trends in epidemiology of dementia and management of patients with cognitive impairment. S.S. Korsakov Journal of Neurology and Psichiatry. 2017;117(6-2):87-95. (In Russ.). https://doi.org/10.17116/jnevro20171176287-95
Babiloni C, Lizio R, Marzano N, et al. Brain neural synchronization and functional coupling in Alzheimer’s disease as revealed by resting state EEG rhythms. Int J Psychophysiol. 2016;103:88-102. https://doi.org/10.1016/j.ijpsycho.2015.02.008
Emelin AYu. New criteria for diagnosing Alzheimer’s disease. Neurology, Neuropsychiatry, Psychosomatics. 2011;3(4):5-8. (In Russ.). https://doi.org/10.14412/2074-2711-2011-337
Koberskaya NN. Alzheimer’s disease: new diagnostic criteria and therapeutic aspects depending on the stage of the disease. Meditsinskiy sovet = Medical Council. 2017;(10):18-24. (In Russ.). https://doi.org/10.21518/2079-701X-2017-10-18-24
Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270-279. https://doi.org/10.1016/j.jalz.2011.03.008
Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in «probable» Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967-972. https://doi.org/10.1136/jnnp.55.10.967
Aoki Y, Takahashi R, Suzuki Y, et al. EEG resting-state networks in Alzheimer’s disease associated with clinical symptoms. Sci Rep. 2023;13(1):3964. https://doi.org/10.1038/s41598-023-30075-3
Wang WY, Yu JT, Liu Y, et al. Voxel-based meta-analysis of grey matter changes in Alzheimer’s disease. Transl Neurodegener. 2015;4:6-9. https://doi.org/10.1186/s40035-015-0027-z
Minoshima S. Imaging Alzheimer’s disease: clinical applications. Neuroimaging Clin N Am. 2003;13(4):769-780. https://doi.org/10.1016/s1052-5149(03)00099-6
Chandra A, Valkimadi PE, Pagano G, et al. Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer’s disease and mild cognitive impairment. Hum Brain Mapp. 2019;40(18):5424-5442. https://doi.org/10.1002/hbm.24782
Uzuegbunam BC, Librizzi D, Hooshyar Yousefi B. PET Radiopharmaceuticals for Alzheimer’s Disease and Parkinson’s Disease Diagnosis, the Current and Future Landscape. Molecules. 2020;25(4):977. https://doi.org/10.3390/molecules25040977
Ding Y, Chu Y, Liu M, et al. Fully automated discrimination of Alzheimer’s disease using resting-state electroencephalography signals. Quant Imaging Med Surg. 2022;12(2):1063-1078. https://doi.org/10.21037/qims-21-430
Keller SM, Reyneke C, Gschwandtner U, et al. Information Contained in EEG Allows Characterization of Cognitive Decline in Neurodegenerative Disorders. Clin EEG Neurosci. 2023;54(4):391-398. https://doi.org/10.1177/15500594221120734
Ivanov LB. Applied computer electroencephalography. M.: JSC «Antidor»; 2000. (In Russ.).
Riekkinen P, Buzsaki G, Riekkinen P Jr, et al. The cholinergic system and EEG slow waves. Electroencephalogr Clin Neurophysiol. 1991;78(2):89-96. https://doi.org/10.1016/0013-4694(91)90107-f
Simfukwe C, Han SH, Jeong HT, et al. qEEG as Biomarker for Alzheimer’s Disease: Investigating Relative PSD Difference and Coherence Analysis. Neuropsychiatr Dis Treat. 2023;19:2423-2437. https://doi.org/10.2147/NDT.S433207
Adamis D, Sahu S, Treloar A. The utility of EEG in dementia: a clinical perspective. Int J Geriatr Psychiatry. 2005;20(11):1038-1045. https://doi.org/10.1002/gps.1393
Riekkinen P Jr, Sirviö J, Riekkinen M, et al. EEG changes induced by acute and chronic quisqualic or ibotenic acid nucleus basalis lesions are stabilized by tacridine. Brain Res. 1991;559(2):304-308. https://doi.org/10.1016/0006-8993(91)90016-o
Brassen S, Adler G. Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial. Pharmacopsychiatry. 2003;36(6):304-308. https://doi.org/10.1055/s-2003-45118
Onofrj M, Thomas A, Iacono D, et al. The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia. Clin Neuropharmacol. 2003;26(5):239-251. https://doi.org/10.1097/00002826-200309000-00008
Adler G, Brassen S, Chwalek K, et al. Prediction of treatment response to rivastigmine in Alzheimer’s dementia. J Neurol Neurosurg Psychiatry. 2004;75(2):292-294.
Jelic V, Kowalski J. Evidence-based evaluation of diagnostic accuracy of resting EEG in dementia and mild cognitive impairment. Clin EEG Neurosci. 2009;40(2):129-142. https://doi.org/10.1177/155005940904000211
Melnikova TS, Storozhakova YaA, Lapin IA, et al. Characteristics of the EEG emotional memory in patients with first episode paranoid schizophrenia. Social and Clinical Psychiatry. 2010;4:39. (In Russ.).
Pachou E, Vourkas M, Simos P, et al. Working memory in schizophrenia: an EEG study using power spectrum and coherence analysis to estimate cortical activation and network behavior. Brain Topogr. 2008;21:128-137.
Alfimova MV, Melnikova TS, Lapin IA. The use of coherent EEG analysis and reactivity to psychophysiological tests in the first episode of schizophrenia. S.S. Korsakov Journal of Neurology and Psichiatry. 2010;110(3):97-102. (In Russ.).
Jelic V, Julin P, Shigeta M, et al. Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer’s disease as measured by EEG coherence. J Neurol Neurosurg Psychiatry. 1997;63(1):59-65. https://doi.org/10.1136/jnnp.63.1.59
Locatelli T, Cursi M, Liberati D, et al. EEG coherence in Alzheimer’s disease. Electroencephalogr Clin Neurophysiol. 1998;106(3):229-237. https://doi.org/10.1016/s0013-4694(97)00129-6
Wada Y, Nanbu Y, Koshino Y, et al. Reduced interhemispheric EEG coherence in Alzheimer disease: analysis during rest and photic stimulation. Alzheimer Dis Assoc Disord. 1998;12(3):175-181. https://doi.org/10.1097/00002093-199809000-00009
Knott V, Mohr E, Mahoney C, et al. Electroencephalographic coherence in Alzheimer’s disease: comparisons with a control group and population norms. J Geriatr Psychiatry Neurol. 2000;13(1):1-8. https://doi.org/10.1177/089198870001300101
Jelic V, Johansson SE, Almkvist O, et al. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer’s disease. Neurobiol Aging. 2000;21(4):533-540. https://doi.org/10.1016/s0197-4580(00)00153-6
Brunovsky M, Matousek M, Edman A, et al. Objective assessment of the degree of dementia by means of EEG. Neuropsychobiology. 2003;48(1):19-26. https://doi.org/10.1159/000071824
Babiloni C, Frisoni GB, Vecchio F, et al. Global functional coupling of resting EEG rhythms is related to white-matter lesions along the cholinergic tracts in subjects with amnesic mild cognitive impairment. J Alzheimers Dis. 2010;19(3):859-871.
Gallego-Jutglà E, Elgendi M, Vialatte F, et al. Diagnosis of Alzheimer’s disease from EEG by means of synchrony measures in optimized frequency bands. Annu Int Conf IEEE Eng Med Biol Soc. 2012;2012:4266-4270. https://doi.org/10.1109/EMBC.2012.6346909
Babiloni C, Frisoni G, Vecchio F, et al. Global functional coupling of resting EEG rhythms is abnormal in mild cognitive impairment and Alzheimer’s disease: A multicenter EEG study. J Psychophysiol. 2009;23(4):224-234. https://doi.org/10.1027/0269-8803.23.4.224
Adler G, Brassen S, Jajcevic A. EEG coherence in Alzheimer’s dementia. J Neural Transm (Vienna). 2003;110(9):1051-1058. https://doi.org/10.1007/s00702-003-0024-8
Aoki Y, Ishii R, Pascual-Marqui RD, et al. Detection of EEG-resting state independent networks by eLORETA-ICA method. Front Hum Neurosci. 2015;9:31. https://doi.org/10.3389/fnhum.2015.00031

Close metadata